Literature DB >> 17768388

Successful engraftment by second cord blood transplantation with reduced-intensity conditioning after graft rejection due to hemophagocytic syndrome following initial CBT.

H Tanaka, C Ohwada, E Sakaida, Y Takeda, D Abe, K Oda, S Ozawa, N Shimizu, S Masuda, R Cho, M Nishimura, Y Saito, C Nakaseko.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17768388     DOI： 10.1038/sj.bmt.1705842

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Graft failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation.

Authors:  Masahiko Sumi; Ikuo Shimizu; Keijiro Sato; Toshimitsu Ueki; Daigo Akahane; Mayumi Ueno; Naoaki Ichikawa; Shinji Nakao; Hikaru Kobayashi
Journal:  Int J Hematol       Date:  2010-11-05       Impact factor: 2.490

2.  Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide.

Authors:  Sarita Rani Jaiswal; Aditi Chakrabarti; Sumita Chatterjee; Sneh Bhargava; Kunal Ray; Suparno Chakrabarti
Journal:  Int J Hematol       Date:  2015-11-30       Impact factor: 2.490

3.  Cord blood transplantation using minimum conditioning regimens for patients with hematologic malignancies complicated by severe infections.

Authors:  Takeshi Yamashita; Chiharu Sugimori; Ken Ishiyama; Hirohito Yamazaki; Hirokazu Okumura; Yukio Kondo; Akiyoshi Takami; Shinji Nakao
Journal:  Int J Hematol       Date:  2008-12-25       Impact factor: 2.490

4.  Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT.

Authors:  R Kobayashi; J Tanaka; S Hashino; S Ota; Y Torimoto; Y Kakinoki; S Yamamoto; M Kurosawa; N Hatakeyama; Y Haseyama; H Sakai; K Sato; T Fukuhara
Journal:  Bone Marrow Transplant       Date:  2013-09-16       Impact factor: 5.483
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.